Overview

A Study of Plazomicin Compared With Levofloxacin for the Treatment of Complicated Urinary Tract Infection (cUTI) and Acute Pyelonephritis (AP)

Status:
Completed

Trial end date:
2012-04-03

Target enrollment:

Participant gender:

Summary

This was a multi-center, multi-national, double-blind, randomized, comparator-controlled study of plazomicin administered intravenously compared with levofloxacin, a standard approved intravenous therapy for complicated urinary tract infection (cUTI) and acute pyelonephritis (AP).

Phase:

Phase 2

Details

Lead Sponsor:

Achaogen, Inc.

Treatments:

Levofloxacin
Ofloxacin